logo
Twitter
Discord
Email
logo
EUDA Health Holdings Limited

EUDA Health Holdings Limited

NASDAQ•EUDA
CEO: Dr. Wei Wen Chen
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Listing Date: 2021-12-14
EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates in two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, and residential apartments, as well as condominiums. EUDA Health Holdings Limited is headquartered in Singapore.
Contact Information
1 Pemimpin Drive #12-06, One Pemimpin, Singapore, 576151, Singapore
65-6268-6821
euda.com
Market Cap
$58.60M
P/E (TTM)
216.0
47.3
Dividend Yield
--
52W High
$4.50
52W Low
$1.03
52W Range
15%
Rank43Top 50.7%
3.8
F-Score
Modified Piotroski Analysis
Based on 5-year fundamentals
Weak • 3.8 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2021-2025

Financial Dashboard

Q2 2025 Data

Revenue

$1.53M+60.23%
4-Quarter Trend

EPS

-$0.02-94.41%
4-Quarter Trend

FCF

-$619.32K-1.68%
4-Quarter Trend

2024 FY Earnings Highlights

Key Highlights

Total Revenue Increased Total Revenues reached 4.01B USD for 2024, showing an 8.2% increase from 3.71B USD reported in 2023.
Fortress Cove Acquisition Closed Completed acquisition of Fortress Cove for $15.0M USD consideration on May 8, 2024, expanding wellness product segment.
Cash Position Strengthened Cash balance increased to 237.6M USD by year-end 2024, up from 189.0M USD at the end of 2023.
Share Count Rises Outstanding ordinary shares grew to 37.15M shares by December 31, 2024, reflecting significant debt conversions and issuances.

Risk Factors

Massive Intangible Impairment Recognized $14.76B USD impairment loss on intangible assets during 2024, significantly impacting operational results.
Going Concern Doubt Substantial doubt exists regarding ability to continue as going concern due to recurring losses and working capital deficit.
Net Loss Widened Net loss attributable to shareholders increased to (15.36B USD) in 2024, worsening from (10.04B USD) loss in 2023.
Related Party Payables High Total related party payables remain substantial at 555.4M USD as of December 31, 2024, requiring ongoing management.

Outlook

Segment Reorganization Complete Reorganized business into two reportable segments: property management and holistic wellness, following Fortress Cove acquisition.
Subsequent Financing Secured Secured multiple new loan agreements totaling over $815K USD from related and third parties in early 2025.
Earnout Targets Missed Determined probability of achieving 2024 and 2025 revenue/income Earnout Share milestones is zero, resulting in zero fair value.

Peer Comparison

Revenue (TTM)

Lucid Diagnostics Inc.LUCD
$1.21B
+28885.2%
DocGo Inc.DCGO
$368.09M
-47.0%
CareCloud, Inc.CCLD
$114.32M
+3.0%

Gross Margin (Latest Quarter)

Opus Genetics, Inc.IRD
99.6%
-0.4pp
CareCloud, Inc.CCLD
47.8%
+1.8pp
EUDA Health Holdings LimitedEUDA
27.3%
+4.2pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
IRD$176.55M-2.7-774.2%3.0%
ONCY$124.45M-4.9-755.2%5.5%
LUCD$123.13M-0.0-123875.2%45.7%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
13.3%
Steady Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
0%
Cash Flow Needs Attention

Research & Insights

Next earnings:May 5, 2026
|
EPS:-
|
Revenue:-
Reports
All Years

  • Form 20-F/A - FY 2024

    Period End: Dec 31, 2024|Filed: Sep 24, 2025|
    Revenue: $4.01M+8.2%
    |
    EPS: $-0.47-27.0%
    Miss

  • Form 20-F/A - FY 2024

    Period End: Dec 31, 2024|Filed: Sep 11, 2025|Refer to amended data

  • Form 20-F - FY 2024

    Period End: Dec 31, 2024|Filed: Apr 29, 2025|Refer to amended data

  • Form 20-F - FY 2023

    Period End: Dec 31, 2023|Filed: May 9, 2024|
    Revenue: $3.71M-1.5%
    |
    EPS: $-0.37+82.1%
    Miss

  • Form 10-Q - Q1 2023

    Period End: Mar 31, 2023|Filed: Jul 31, 2023|
    Revenue: $1.70M-36.3%
    |
    EPS: $-0.12-697.0%
    N/A

  • Form 10-K - FY 2022

    Period End: Dec 31, 2022|Filed: Jun 28, 2023|
    Revenue: $3.76M-17.4%
    |
    EPS: $-2.07-2313.9%
    N/A

  • Form 10-Q - Q3 2022

    Period End: Oct 31, 2022|Filed: Nov 22, 2022|
    Revenue: $2.31M-14.2%
    |
    EPS: $-0.07+1323.4%
    N/A

  • Form 10-K - FY 2022

    Period End: Jul 31, 2022|Filed: Aug 29, 2022|Refer to amended data